Search Results 1341-1350 of 18865 for Fungus

1. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Single Lung Transplantation - Mayo Clinic

   Active acute bacterial, viral, or fungal infection not successfully resolved at least 4 weeks prior to the Screening Visit. Patients with chronic infection ...

2. Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis - Mayo Clinic

   ... fungal) * Patients on renal replacement therapy * Known GI disease or GI procedure that could interfere with oral absorption (including difficulty ...

3. Publications - Angela M. Donaldson, M.D. - Mayo Clinic

   COVID-19-Associated Acute Invasive Fungal Rhinosinusitis Journal of Neurological Surgery Part B. 2022; 83:P028. Martinez-Paredes JF, Choby G, Marino M, Lal ...

4. Publications - Venkatesh R. Bellamkonda, M.D. - Mayo Clinic

   Atypical Fungal Rash. Clin Pract Cases Emerg Med. 2019 May; 3 (2):166-167 Epub 2019 Feb 26. View PubMed; Bellew SD, Colbenson KM, Bellamkonda VR. Posterior ...

5. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Any active Grade 3 or higher viral, bacterial, or fungal infection within 2 weeks of the first dose of the study drug. Routine antimicrobial prophylaxis is ...

6. A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma - Mayo Clinic

   The participant has a known active fungal, bacterial, or viral infection including human immunodeficiency virus (HIV) or viral (A, B, or C) hepatitis (screening ...

7. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

8. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   Any active grade 3 or higher (per NCI CTCAE version 4.03) viral, bacterial, or fungal infection within 2 weeks of the first dose of the study drug. Routine ...

9. Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) - Mayo Clinic

   Active systemic or organ system bacterial or fungal infection or progressive severe infection (including unresolved or untreated N. meningitidis infection ...

10. Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer - Mayo Clinic

    Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration; Chronic obstructive pulmonary disease exacerbation or ...